Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.
暂无分享,去创建一个
J. Garber | S. Rivkees | V. Montori | D. Ross | J. Sosa | I. Klein | D. Cooper | M. Stan | R. Bahn | P. Laurberg | H. Burch | I. McDougall | M. C. Greenlee | Victor M. Montori | Peter Laurberg | Henry B. Burch | I. McDougall | Julie Ann Sosa | David S. Cooper | Irwin Klein | Douglas S. Ross | Marius N Stan
[1] Bethany J Figg,et al. National Institute of Child Health and Human Development , 2013 .
[2] R. Paschke,et al. Genetics and phenomics of inherited and sporadic non-autoimmune hyperthyroidism , 2010, Molecular and Cellular Endocrinology.
[3] Paolo Vitti,et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. , 2010, Journal of endocrinological investigation.
[4] J. Franklyn,et al. Older subjects with hyperthyroidism present with a paucity of symptoms and signs: a large cross-sectional study. , 2010, The Journal of clinical endocrinology and metabolism.
[5] H. Gharib,et al. AACE / AME / ETA Guidelines AMERICAN ASSOCIATION Of ClINICAl ENDOCRINOlOgISTS , ASSOCIAzIONE MEDICI ENDOCRINOlOgI , AND EuROPEAN ThyROID ASSOCIATION MEDICAl guIDElINES fOR ClINICAl PRACTICE fOR ThE DIAgNOSIS AND MANAgEMENT Of ThyROID NODulES , 2010 .
[6] H. Gharib,et al. American Association of Clinical Endocrinologists Protocol for Standardized Production of Clinical Practice Guidelines--2010 update. , 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[7] L. Bartalena,et al. Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent graves' orbitopathy: a retrospective cohort study. , 2010, The Journal of clinical endocrinology and metabolism.
[8] S. Rivkees,et al. Adverse Events Associated with Methimazole Therapy of Graves' Disease in Children , 2010, International journal of pediatric endocrinology.
[9] V. Simha,et al. Antineutrophil cytoplasmic antibody-positive vasculitis in a patient with graves disease: cross-reaction between propylthiouracil and methimazole. , 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[10] M. Mossanen,et al. An Algorithm Informed by the Parathyroid Hormone Level Reduces Hypocalcemic Complications of Thyroidectomy , 2010, World Journal of Surgery.
[11] S. Rivkees,et al. Ending propylthiouracil-induced liver failure in children. , 2009, The New England journal of medicine.
[12] D. Steward,et al. The Role of Rapid Pacu Parathyroid Hormone in Reducing Post-Thyroidectomy Hypocalcemia , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[13] Stephanie L. Lee,et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.
[14] A. Taube,et al. Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131. , 2009, The Journal of clinical endocrinology and metabolism.
[15] Stephanie L. Lee,et al. Prediction of hypocalcemia after using 1‐ to 6‐hour postoperative parathyroid hormone and calcium levels: An analysis of pooled individual patient data from 3 observational studies , 2009, Head & neck.
[16] D. Dazzi,et al. Graves' orbitopathy activation after radioactive iodine therapy with and without steroid prophylaxis. , 2009, The Journal of clinical endocrinology and metabolism.
[17] Kunihiko Ito,et al. Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs. , 2009, The Journal of clinical endocrinology and metabolism.
[18] L. Kovács,et al. The efficacy of long term thyrostatic treatment in elderly patients with toxic nodular goitre compared to radioiodine therapy with different doses. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[19] R. Wahl,et al. Differentiated operative therapy of thyroid autonomy (Plummer's disease). , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[20] J. Garber,et al. The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. , 2009, Thyroid : official journal of the American Thyroid Association.
[21] S. Roman,et al. Outcomes following thyroid and parathyroid surgery in pregnant women. , 2009, Archives of surgery.
[22] W. Roberts,et al. Method specific second-trimester reference intervals for thyroid-stimulating hormone and free thyroxine. , 2009, Clinical biochemistry.
[23] S. Rivkees,et al. Propylthiouracil (PTU) Hepatoxicity in Children and Recommendations for Discontinuation of Use , 2009, International journal of pediatric endocrinology.
[24] L. Braverman,et al. Free T4 immunoassays are flawed during pregnancy. , 2009, American journal of obstetrics and gynecology.
[25] S. Zakavi,et al. Comparison of four different protocols of I-131 therapy for treating single toxic thyroid nodule , 2009, Nuclear medicine communications.
[26] N. Kamel,et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibody in Graves’ patients treated with propylthiouracil , 2009, International journal of clinical practice.
[27] S. Bandinelli,et al. Thyroid Function Abnormalities and Cognitive Impairment in Elderly People: Results of the Invecchiare in Chianti Study , 2009, Journal of the American Geriatrics Society.
[28] S. Roman,et al. Pediatric endocrine surgery: who is operating on our children? , 2008, Surgery.
[29] G. Paz-Filho,et al. Thiamazole as an adjuvant to radioiodine for volume reduction of multinodular goiter , 2008, Expert opinion on investigational drugs.
[30] K. Nair,et al. Changes in body composition in women following treatment of overt and subclinical hyperthyroidism. , 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[31] J. Magner. Problems associated with the use of thyrogen in patients with a thyroid gland. , 2008, The New England journal of medicine.
[32] P. Czernichow,et al. Predictors of autoimmune hyperthyroidism relapse in children after discontinuation of antithyroid drug treatment. , 2008, The Journal of clinical endocrinology and metabolism.
[33] S. Gamba,et al. Long-term follow-up of patients with hyperthyroidism due to Graves’ disease treated with methimazole. Comparison of usual treatment schedule with drug discontinuation vs continuous treatment with low methimazole doses: A retrospective study , 2008, Journal of endocrinological investigation.
[34] R. Jorde,et al. Prevalence and causes of undiagnosed hyperthyroidism in an adult healthy population. The Tromsø study , 2008, Journal of endocrinological investigation.
[35] R. Kloos,et al. Evaluation of various doses of recombinant human thyrotropin in patients with multinodular goiters. , 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[36] B. Velkeniers,et al. Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies. , 2008, European journal of endocrinology.
[37] J. Hershman. The role of human chorionic gonadotropin as a thyroid stimulator in normal pregnancy. , 2008, The Journal of clinical endocrinology and metabolism.
[38] S. Rivkees,et al. Clinical and economic outcomes of thyroid and parathyroid surgery in children. , 2008, The Journal of clinical endocrinology and metabolism.
[39] W. Wiersinga,et al. Frequency and characteristics of TBII‐seronegative patients in a population with untreated Graves’ hyperthyroidism: a prospective study , 2008, Clinical endocrinology.
[40] Chao Ma,et al. Radioiodine treatment for pediatric Graves' disease. , 2008, The Cochrane database of systematic reviews.
[41] J. O'Loughlin,et al. Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials , 2008, Canadian Medical Association Journal.
[42] B. Hoffman,et al. Free thyroxine reference interval in each trimester of pregnancy determined with the Roche Modular E-170 electrochemiluminescent immunoassay. , 2008, Clinical biochemistry.
[43] D. Bauer,et al. Meta-analysis: Subclinical Thyroid Dysfunction and the Risk for Coronary Heart Disease and Mortality , 2008, Annals of Internal Medicine.
[44] S. Roman,et al. A population-based study of outcomes from thyroidectomy in aging Americans: at what cost? , 2008, Journal of the American College of Surgeons.
[45] G. Lundell,et al. Incidence of hyperthyroidism in Stockholm, Sweden, 2003-2005. , 2008, European journal of endocrinology.
[46] L. Rubert,et al. Meta-variability of advice on drugs in the breastfeeding mother: the example of β-blockers , 2008, Archives of Disease in Childhood Fetal and Neonatal Edition.
[47] D. Farley,et al. Evidence-based Management of Toxic Multinodular Goiter (Plummer’s Disease) , 2008, World Journal of Surgery.
[48] M. Nardi,et al. Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy. , 2008, Thyroid : official journal of the American Thyroid Association.
[49] G. Guyatt,et al. A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. , 2008, The Journal of clinical endocrinology and metabolism.
[50] D. Styne,et al. Predicting the Likelihood of Remission in Children With Graves’ Disease: A Prospective, Multicenter Study , 2008, Pediatrics.
[51] D. Parmeggiani,et al. Percutaneous ethanol injection of hyperfunctioning thyroid nodules: long-term follow-up in 125 patients. , 2008, AJR. American journal of roentgenology.
[52] M. Hier,et al. Cost savings associated with post-thyroidectomy parathyroid hormone levels , 2008, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[53] A. Kessler,et al. Hypothyroidism following partial thyroidectomy , 2008, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[54] Stephanie L. Lee,et al. Early prediction of hypocalcemia after thyroidectomy using parathyroid hormone: an analysis of pooled individual patient data from nine observational studies. , 2007, Journal of the American College of Surgeons.
[55] S. Roman,et al. Racial Disparities in Clinical and Economic Outcomes From Thyroidectomy , 2007, Annals of surgery.
[56] Rosalind S. Brown,et al. Persistence of thyrotropin (TSH) receptor antibodies in children and adolescents with Graves' disease treated using antithyroid medication. , 2007, Thyroid : official journal of the American Thyroid Association.
[57] P. Vitti,et al. Could improved ultrasound and power Doppler replace thyroidal radioiodine uptake to assess thyroid disease? , 2007, Nature Clinical Practice Endocrinology &Metabolism.
[58] S. Rivkees. Graves' disease therapy in children: truth and inevitable consequences. , 2007, Journal of pediatric endocrinology & metabolism : JPEM.
[59] M. Yeh,et al. PARATHYROID HORMONE ASSAY PREDICTS HYPOCALCAEMIA AFTER TOTAL THYROIDECTOMY , 2007, ANZ journal of surgery.
[60] A. L'Abbate,et al. Association between increased mortality and mild thyroid dysfunction in cardiac patients. , 2007, Archives of internal medicine.
[61] M. Surks,et al. Serum thyrotropin measurements in the community: five-year follow-up in a large network of primary care physicians. , 2007, Archives of internal medicine.
[62] N. Kapucuoglu,et al. Thyroid cancer in toxic and non-toxic multinodular goiter. , 2007, Journal of postgraduate medicine.
[63] S. Mandel,et al. Therapy Insight: management of Graves' disease during pregnancy , 2007, Nature Clinical Practice Endocrinology &Metabolism.
[64] H. Issever,et al. Effect of lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves' disease. , 2007, The Journal of clinical endocrinology and metabolism.
[65] A. Miyauchi,et al. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. , 2007, The Journal of clinical endocrinology and metabolism.
[66] A. Auvinen,et al. Increased cancer incidence after radioiodine treatment for hyperthyroidism , 2007, Cancer.
[67] F. Andersohn,et al. Systematic Review: Agranulocytosis Induced by Nonchemotherapy Drugs , 2007, Annals of Internal Medicine.
[68] V. Sridama,et al. Proptosis in normal Thai samples and thyroid patients. , 2007, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[69] O. Clark,et al. The optimal treatment for pediatric Graves' disease is surgery. , 2007, The Journal of clinical endocrinology and metabolism.
[70] S. Rivkees,et al. An optimal treatment for pediatric Graves' disease is radioiodine. , 2007, The Journal of clinical endocrinology and metabolism.
[71] Beata Wojtczak,et al. Influence of Total Thyroidectomy on Orbital Opthalmopathy and Levels of Antithyroid Antibodies in Patients with Graves' Disease , 2007 .
[72] M. Briel,et al. Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials , 2007, BMJ : British Medical Journal.
[73] M. Mori,et al. Treatment for childhood-onset Graves' disease in Japan: results of a nationwide questionnaire survey of pediatric endocrinologists and thyroidologists. , 2007, Thyroid : official journal of the American Thyroid Association.
[74] K. Burman,et al. Thyrotoxicosis and thyroid storm. , 2006, Endocrinology and metabolism clinics of North America.
[75] S. Mezitis,et al. A case of acute suppurative thyroiditis complicated by thyrotoxicosis , 2006, Journal of endocrinological investigation.
[76] D. Farley,et al. Surgical management of Graves disease in childhood and adolescence: an institutional experience. , 2006, Surgery.
[77] C. Son,et al. Diffuse Alveolar Hemorrhage Associated with Antineutrophil Cytoplasmic Antibody levels in a Pregnant Woman Taking Propylthiouracil , 2006, The Korean journal of internal medicine.
[78] M. Aguilar-Diosdado,et al. Concomitant Agranulocytosis and Hepatotoxicity After Treatment with Carbimazole , 2006, The Annals of pharmacotherapy.
[79] K. Nair,et al. Changes in skeletal muscle protein metabolism and myosin heavy chain isoform messenger ribonucleic acid abundance after treatment of hyperthyroidism. , 2006, The Journal of clinical endocrinology and metabolism.
[80] J. Roh,et al. Routine oral calcium and vitamin D supplements for prevention of hypocalcemia after total thyroidectomy. , 2006, American journal of surgery.
[81] M. Cakir,et al. Incidental Thyroid Carcinoma in Thyrotoxic Patients Treated by Surgery , 2006, Hormone Research in Paediatrics.
[82] J. Franklyn,et al. Is Subclinical Thyroid Dysfunction in the Elderly Associated with Depression or Cognitive Dysfunction? , 2006, Annals of Internal Medicine.
[83] C. Sempoux,et al. Propylthiouracyl-induced severe liver toxicity: an indication for alanine aminotransferase monitoring? , 2006, World journal of gastroenterology.
[84] P. Leedman,et al. Subclinical thyroid dysfunction and blood pressure: a community‐based study , 2006, Clinical endocrinology.
[85] A. Pinchera,et al. Testicular function after 131I therapy for hyperthyroidism , 2006, Clinical endocrinology.
[86] N. Morgenthaler,et al. Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease. , 2006, The Journal of clinical endocrinology and metabolism.
[87] N. Foulds,et al. Antenatal carbimazole and choanal atresia: a new embryopathy. , 2006, Archives of otolaryngology--head & neck surgery.
[88] Silvia G Priori,et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Commit , 2006, Journal of the American College of Cardiology.
[89] G. Saade,et al. Pharmacokinetics and Pharmacotherapy of Thionamides in Pregnancy , 2006, Therapeutic drug monitoring.
[90] N. Venkataramana,et al. Aplasia cutis congenita of the scalp: therapeutic modalities. , 2006, Neurology India.
[91] S. Pearce,et al. What is the evidence behind the evidence-base? The premature death of block-replace antithyroid drug regimens for Graves' disease. , 2006, European journal of endocrinology.
[92] R. Porsche,et al. Amiodarone-induced thyroid dysfunction. , 2006, Critical care nurse.
[93] R. Yeatts. Quality of life in patients with Graves ophthalmopathy. , 2006, Transactions of the American Ophthalmological Society.
[94] W. Hsu,et al. Exophthalmos of patients with Graves' disease in Chinese of Taiwan , 2006, Eye.
[95] K. Kaufman,et al. The impact of overt and subclinical hyperthyroidism on skeletal muscle. , 2006, Thyroid : official journal of the American Thyroid Association.
[96] H. Yamashita,et al. Prognosis of small thyroid cancer in patients with Graves' disease , 2006, The British journal of surgery.
[97] A. Stojadinovic,et al. The use of rapid parathyroid hormone assay in predicting postoperative hypocalcemia after total or completion thyroidectomy. , 2006, Thyroid : official journal of the American Thyroid Association.
[98] J. Boice. Thyroid disease 60 years after Hiroshima and 20 years after Chernobyl. , 2006, JAMA.
[99] J. Dashe,et al. Subclinical Hyperthyroidism and Pregnancy Outcomes , 2006, Obstetrics and gynecology.
[100] M. Cappa,et al. Influence of gender and pubertal stage at diagnosis on growth outcome in childhood thyrotoxicosis: results of a collaborative study , 2006, Clinical endocrinology.
[101] N. Paunković,et al. Does Autoantibody-negative Graves’ Disease Exist? A Second Evaluation of the Clinical Diagnosis , 2006, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[102] B. Hamberger,et al. Graves' disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery. , 2005, Thyroid : official journal of the American Thyroid Association.
[103] J. Rastad,et al. Graves' disease with moderate-severe endocrine ophthalmopathy-long term results of a prospective, randomized study of total or subtotal thyroid resection. , 2005, Thyroid : official journal of the American Thyroid Association.
[104] A. Avenell,et al. A systematic review of drug therapy for Graves' hyperthyroidism. , 2005, European journal of endocrinology.
[105] Shing M. Lee,et al. Thyroidectomy using local anesthesia: a report of 1,025 cases over 16 years. , 2005, Journal of the American College of Surgeons.
[106] P. Perros,et al. A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active graves' ophthalmopathy. , 2005, The Journal of clinical endocrinology and metabolism.
[107] K. Woeber. Observations concerning the natural history of subclinical hyperthyroidism. , 2005, Thyroid : official journal of the American Thyroid Association.
[108] J. Franklyn,et al. Thyroid function and mortality in patients treated for hyperthyroidism. , 2005, JAMA.
[109] Yan Liu,et al. Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study , 2005, The Lancet.
[110] D. Wyatt,et al. Effective Methimazole Dose for Childhood Graves' Disease and Use of Free Triiodothyronine Combined with Concurrent Thyroid Stimulating Hormone Level to Identify Mild Hyperthyroidism and Delayed Pituitary Recovery , 2005, Journal of pediatric endocrinology & metabolism : JPEM.
[111] J. Boice. Radiation-induced thyroid cancer--what's new? , 2005, Journal of the National Cancer Institute.
[112] S. Noguchi,et al. Antithyroid drug-induced agranulocytosis: how has granulocyte colony-stimulating factor changed therapy? , 2005, Thyroid : official journal of the American Thyroid Association.
[113] A. Pinchera,et al. Outcome of radioiodine‐131 therapy in hyperfunctioning thyroid nodules: a 20 years’ retrospective study , 2005, Clinical endocrinology.
[114] S. Mandel,et al. Are detection and treatment of thyroid insufficiency in pregnancy feasible? , 2005, Thyroid : official journal of the American Thyroid Association.
[115] J. Jonklaas,et al. Trimester-specific changes in maternal thyroid hormone, thyrotropin, and thyroglobulin concentrations during gestation: trends and associations across trimesters in iodine sufficiency. , 2004, Thyroid : official journal of the American Thyroid Association.
[116] A. D. de Craen,et al. Thyroid status, disability and cognitive function, and survival in old age. , 2004, JAMA.
[117] Scott Davis,et al. Thyroid neoplasia, autoimmune thyroiditis, and hypothyroidism in persons exposed to iodine 131 from the hanford nuclear site. , 2004, JAMA.
[118] R. B. Wilcox,et al. The nature of analogue-based free thyroxine estimates. , 2004, Thyroid : official journal of the American Thyroid Association.
[119] M. Eckman,et al. Radioiodine or surgery for toxic thyroid adenoma: dissecting an important decision. A cost-effectiveness analysis. , 2004, Thyroid : official journal of the American Thyroid Association.
[120] S. Woodings. Radiation protection recommendations for I-131 thyrotoxicosis, thyroid cancer and phaeochromocytoma patients , 2004, Australasian Physics & Engineering Sciences in Medicine.
[121] M. Tansey,et al. A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' patients. , 2004, The Journal of clinical endocrinology and metabolism.
[122] J. Romaldini,et al. Propylthiouracil reduces the effectiveness of radioiodine treatment in hyperthyroid patients with Graves' disease. , 2004, Thyroid : official journal of the American Thyroid Association.
[123] C. Carella,et al. Interferon-α-Related Thyroid Disease: Pathophysiological, Epidemiological, and Clinical Aspects , 2004 .
[124] G. Bifulco,et al. Reduced bone mass detected by bone quantitative ultrasonometry and DEXA in pre- and postmenopausal women with endogenous subclinical hyperthyroidism. , 2004, Maturitas.
[125] G. Guyatt,et al. Grading quality of evidence and strength of recommendations , 2004, BMJ : British Medical Journal.
[126] D. Luton,et al. Fetal and neonatal thyroid function in relation to maternal Graves' disease. , 2004, Best practice & research. Clinical endocrinology & metabolism.
[127] C. Salmaso,et al. Use of an artificial neural network to predict Graves’ disease outcome within 2 years of drug withdrawal , 2004, European journal of clinical investigation.
[128] J. Franklyn,et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. , 2004, JAMA.
[129] F. Frattaroli,et al. Total compared with subtotal thyroidectomy in benign nodular disease: personal series and review of published reports. , 2003, The European journal of surgery = Acta chirurgica.
[130] J. Marving,et al. Resumption of methimazole after 131I therapy of hyperthyroid diseases: effect on thyroid function and volume evaluated by a randomized clinical trial. , 2003, European journal of endocrinology.
[131] A. Baker,et al. Consent and anaesthetic risk , 2003, Anaesthesia.
[132] Per Hall,et al. Thyroid cancer risk after thyroid examination with 131I: A population‐based cohort study in Sweden , 2003, International journal of cancer.
[133] Burchell Hb,et al. Thyroid cancer yield in patients with Graves' disease. , 2003 .
[134] J. Díez. Hyperthyroidism in Patients Older than 55 Years: An Analysis of the Etiology and Management , 2003, Gerontology.
[135] D. Cooper. Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies. , 2003, The Journal of clinical endocrinology and metabolism.
[136] P. Laurberg,et al. Interferon-alpha and autoimmune thyroid disease. , 2003, Thyroid : official journal of the American Thyroid Association.
[137] E. Atkinson,et al. Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study. , 2003, The Journal of clinical endocrinology and metabolism.
[138] P. Chanson,et al. The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. , 2003, European journal of endocrinology.
[139] S. Rivkees,et al. Influence of iodine-131 dose on the outcome of hyperthyroidism in children. , 2003, Pediatrics.
[140] J. Romaldini,et al. The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities. , 2003, The Journal of clinical endocrinology and metabolism.
[141] I. Mcdougall,et al. How should the dose of iodine-131 be determined in the treatment of Graves' hyperthyroidism? , 2003, The Journal of clinical endocrinology and metabolism.
[142] W. Leslie,et al. A randomized comparison of radioiodine doses in Graves' hyperthyroidism. , 2003, The Journal of clinical endocrinology and metabolism.
[143] M. Erdoğan,et al. A stepwise approach to the treatment of amiodarone-induced thyrotoxicosis. , 2003, Thyroid : official journal of the American Thyroid Association.
[144] V. Trischitta,et al. Percutaneous ethanol injection plus radioiodine versus radioiodine alone in the treatment of large toxic thyroid nodules. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[145] J. Ruiz,et al. Fulminant Hepatic Failure Associated with Propylthiouracil , 2003, The Annals of pharmacotherapy.
[146] G. Thompson,et al. Current treatment of nodular goiter with hyperthyroidism (Plummer's disease): surgery versus radioiodine. , 2002, Surgery.
[147] C. Lombardi,et al. Is routine supplementation therapy (calcium and vitamin D) useful after total thyroidectomy? , 2002, Surgery.
[148] E. Salpeter,et al. Cardioselective -Blockers in Patients with Reactive Airway Disease , 2002, Annals of Internal Medicine.
[149] Richard Hellman,et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. , 2002, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[150] S. Skeie,et al. Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves' disease. , 2002, European journal of endocrinology.
[151] M. Hier,et al. Predicting Calcium Status Post Thyroidectomy with Early Calcium Levels , 2002, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[152] A. Madec,et al. Reduction of the risk of relapse after withdrawal of medical therapy for Graves' disease. , 2002, Thyroid : official journal of the American Thyroid Association.
[153] A. Stagnaro-Green,et al. Clinical review 152: Postpartum thyroiditis. , 2002, The Journal of clinical endocrinology and metabolism.
[154] M. González-Ortiz,et al. Remission of Graves' hyperthyroidism treated with methimazole. , 2002, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.
[155] E. Eugster,et al. Time course to hypothyroidism after fixed-dose radioablation therapy of Graves' disease in children. , 2002, The Journal of pediatrics.
[156] Mathew R. Williams,et al. Thyroidectomy using local anesthesia in critically ill patients with amiodarone-induced thyrotoxicosis: a review and description of the technique. , 2002, Thyroid : official journal of the American Thyroid Association.
[157] K. Woeber. Methimazole-induced hepatotoxicity. , 2002, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[158] E. Roti,et al. Post-partum thyroiditis--a clinical update. , 2002, European journal of endocrinology.
[159] P. Larsen,et al. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease. , 2002, The Journal of clinical endocrinology and metabolism.
[160] W Harry Hannon,et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). , 2002, The Journal of clinical endocrinology and metabolism.
[161] E. Kulinskaya,et al. Does smoking increase relapse rates in Graves’ disease? , 2002, Journal of endocrinological investigation.
[162] A. Weetman,et al. Clinical experience of amiodarone‐induced thyrotoxicosis over a 3‐year period: role of colour‐flow Doppler sonography * , 2002, Clinical endocrinology.
[163] G. Daniels,et al. Association between lithium use and thyrotoxicosis caused by silent thyroiditis , 2001, Clinical endocrinology.
[164] J. Mehlsen,et al. Haemodynamic changes following treatment of subclinical and overt hyperthyroidism. , 2001, European journal of endocrinology.
[165] J. Franklyn,et al. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study , 2001, The Lancet.
[166] P. Laurberg,et al. TSH‐receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays , 2001, Clinical endocrinology.
[167] K. Heller,et al. Re‐operation for bleeding after thyroidectomy and parathyroidectomy , 2001, Head & neck.
[168] R. Howard,et al. The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after (131)I ablation for Graves' disease. , 2001, The Journal of clinical endocrinology and metabolism.
[169] A. Hisham,et al. Total thyroidectomy: the procedure of choice for multinodular goitre. , 2001, The European journal of surgery = Acta chirurgica.
[170] D. Glinoer,et al. Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study. , 2001, European journal of endocrinology.
[171] P. Gruppuso,et al. Thyroid storm in a child following radioactive iodine (RAI) therapy: a consequence of RAI versus withdrawal of antithyroid medication. , 2001, The Journal of clinical endocrinology and metabolism.
[172] D. Bauer,et al. Risk for Fracture in Women with Low Serum Levels of Thyroid-Stimulating Hormone , 2001, Annals of Internal Medicine.
[173] Dianne M Loomis,et al. Appendicitis in pregnancy. , 1951, Journal of the American Board of Family Medicine : JABFM.
[174] S. Dong,et al. The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study , 2001, American Journal of Gastroenterology.
[175] B. Biondi,et al. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. , 2000, The Journal of clinical endocrinology and metabolism.
[176] M. Minuto,et al. Doppler evaluation of intrathyroid arterial resistances during preoperative treatment with Lugol's iodide solution in patients with diffuse toxic goiter. , 2000, Journal of the American College of Surgeons.
[177] A Hofman,et al. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study , 2000, Clinical endocrinology.
[178] M. Inaba,et al. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism. , 2000, The Journal of clinical endocrinology and metabolism.
[179] M. Phillip,et al. Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal patients. , 2000, The Journal of clinical endocrinology and metabolism.
[180] N. Takasu,et al. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment. , 2000, Thyroid : official journal of the American Thyroid Association.
[181] M. Akmal,et al. Radioiodine dosimetry in patients with end-stage renal disease receiving continuous ambulatory peritoneal dialysis therapy. , 2000, The Journal of clinical endocrinology and metabolism.
[182] M. Goodarzi,et al. Thyrotoxicosis in a male patient associated with excess human chorionic gonadotropin production by germ cell tumor. , 2000, Thyroid : official journal of the American Thyroid Association.
[183] J. Dötsch,et al. Diagnosis and Management of Juvenile Hyperthyroidism in Germany: A Retrospective Multicenter Study , 2000, Journal of pediatric endocrinology & metabolism : JPEM.
[184] A. McElduff,et al. Prevalence of positive anti-neutrophil cytoplasmic antibody (ANCA) in patients receiving anti-thyroid medication. , 2000, European journal of endocrinology.
[185] P. Crowe,et al. Hypomagnesemia and Hypocalcemia after Thyroidectomy: Prospective Study , 2000, World Journal of Surgery.
[186] C. Miller,et al. The efficacy of thyroidectomy for Graves' disease: A meta-analysis. , 2000, The Journal of surgical research.
[187] S. Mishra,et al. Total Thyroidectomy for Benign Thyroid Disorders in an Endemic Region , 2000, World Journal of Surgery.
[188] R. Toohey,et al. The AAPM/RSNA physics tutorial for residents: internal radiation dosimetry: principles and applications. , 2000, Radiographics : a review publication of the Radiological Society of North America, Inc.
[189] J. Franklyn,et al. Age and gender predict the outcome of treatment for Graves' hyperthyroidism. , 2000, The Journal of clinical endocrinology and metabolism.
[190] A. Maia,et al. Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism. , 1999, The Journal of clinical endocrinology and metabolism.
[191] J. H. Schade,et al. Clinical and biochemical changes following 131I therapy for hyperthyroidism in patients not pretreated with antithyroid drugs. , 1999, The Netherlands journal of medicine.
[192] L. Hegedüs,et al. The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function. , 1999, The Journal of clinical endocrinology and metabolism.
[193] N. Amino,et al. Postpartum autoimmune thyroid syndrome: a model of aggravation of autoimmune disease. , 1999, Thyroid : official journal of the American Thyroid Association.
[194] C. Gorman,et al. Radioiodine and pregnancy. , 1999, Thyroid : official journal of the American Thyroid Association.
[195] L. Delbridge,et al. Age is no contraindication to thyroid surgery. , 1999, Age and ageing.
[196] J. Hershman. Human chorionic gonadotropin and the thyroid: hyperemesis gravidarum and trophoblastic tumors. , 1999, Thyroid : official journal of the American Thyroid Association.
[197] L. Hegedüs,et al. Radioiodine therapy for multinodular toxic goiter. , 1999, Archives of internal medicine.
[198] H. Burch,et al. Amiodarone-Induced Thyroid Dysfunction , 1999 .
[199] L. Hegedüs,et al. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy. , 1999, Thyroid : official journal of the American Thyroid Association.
[200] M. Salvatori,et al. Diagnostic imaging in thyrotoxicosis. , 1999, Rays.
[201] U. Burkhardt,et al. Risk of iodine-induced thyrotoxicosis after coronary angiography: an investigation in 788 unselected subjects. , 1999, European journal of endocrinology.
[202] L. Hegedüs,et al. Long‐term effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules , 1999, Clinical endocrinology.
[203] A. Pinchera,et al. Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves' hyperthyroidism. , 1999, The Journal of clinical endocrinology and metabolism.
[204] P. Laurberg,et al. Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association. , 1998, European journal of endocrinology.
[205] S. Rivkees,et al. Clinical review 99: The management of Graves' disease in children, with special emphasis on radioiodine treatment. , 1998, The Journal of clinical endocrinology and metabolism.
[206] N. Powe,et al. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. , 1998, Annals of surgery.
[207] M. Doody,et al. Cancer Mortality Following Treatment for Adult Hyperthyroidism , 1998 .
[208] C. Terwee,et al. Development of a disease specific quality of life questionnaire for patients with Graves’ ophthalmopathy: the GO-QOL , 2022 .
[209] M. Waseem,et al. Successful outcome with methimazole and lithium combination therapy for propylthiouracil-induced hepatotoxicity. , 1998, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[210] W. Wiersinga,et al. Prediction of post partum thyroid dysfunction: can it be improved? , 1998, European journal of endocrinology.
[211] B Nygaard,et al. Observer variation in the clinical and laboratory evaluation of patients with thyroid dysfunction and goiter. , 1998, Thyroid : official journal of the American Thyroid Association.
[212] H. Gharib,et al. Treatment of patients with toxic multinodular goiter. , 1998, Thyroid : official journal of the American Thyroid Association.
[213] J. Franklyn,et al. Mortality after the treatment of hyperthyroidism with radioactive iodine. , 1998, The New England journal of medicine.
[214] Faber,et al. Normalization of serum thyrotrophin by means of radioiodine treatment in subclinical hyperthyroidism: effect on bone loss in postmenopausal women , 1998, Clinical endocrinology.
[215] R. Siegel,et al. Toxic nodular goiter. Toxic adenoma and toxic multinodular goiter. , 1998, Endocrinology and metabolism clinics of North America.
[216] D. Ross. Syndromes of thyrotoxicosis with low radioactive iodine uptake. , 1998, Endocrinology and metabolism clinics of North America.
[217] L. Jacobsson,et al. Radioiodine treatment of hyperthyroidism in a pregnant women. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[218] M. Nardi,et al. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. , 1998, The New England journal of medicine.
[219] P. Yeo,et al. Interferon-α Induced Thyroid Dysfunction: Three Clinical Presentations and a Review of the Literature , 1997 .
[220] N. Ishikawa,et al. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism. , 1997, The Journal of clinical endocrinology and metabolism.
[221] D. Shulman,et al. Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison of clinical and biochemical features at diagnosis and responses to medical therapy. , 1997, Thyroid : official journal of the American Thyroid Association.
[222] W. Wiersinga,et al. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy , 1997, Clinical endocrinology.
[223] D. Glinoer,et al. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. , 1997, Endocrine reviews.
[224] D. Styne,et al. Predictors of early remission of hyperthyroidism in children. , 1997 .
[225] C. Reiners,et al. Treatment of Graves' hyperthyroidism with radioiodine: results of a prospective randomized study. , 1997, Thyroid : official journal of the American Thyroid Association.
[226] A. Casolaro,et al. Five‐year follow‐up of percutaneous ethanol injection for the treatment of hyperfunctioning thyroid nodules: a study of 117 patients , 1997, Clinical endocrinology.
[227] A. Pinchera,et al. Surgical treatment of Graves' disease: subtotal or total thyroidectomy? , 1996, Surgery.
[228] F. Brucker-Davis,et al. Thyrotropin-secreting pituitary tumors. , 1996, Endocrinology and metabolism clinics of North America.
[229] L. Braverman,et al. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha. , 1996, The American journal of medicine.
[230] E. Reschini,et al. Treatment of the autonomous thyroid nodule: a review. , 1996, European journal of endocrinology.
[231] R. Ziegler,et al. Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption , 1996, Clinical endocrinology.
[232] F. Bogazzi,et al. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. , 1996, The Journal of clinical endocrinology and metabolism.
[233] F. Martin,et al. A prospective study of the effect of nonionic contrast media on thyroid function. , 1996, Thyroid : official journal of the American Thyroid Association.
[234] F. Martin,et al. Hyperthyroidism in elderly hospitalised patients: Clinical features and treatment outcomes , 1996, The Medical journal of Australia.
[235] C. Reiners,et al. Reduction in thyroid volume after radioiodine therapy of Graves' hyperthyroidism: results of a prospective, randomized, multicentre study , 1996, European journal of clinical investigation.
[236] M. Surks,et al. Drugs and thyroid function. , 1995, The New England journal of medicine.
[237] J. Benichou,et al. Genetic and Clinical Features of 42 Kindreds with Resistance to Thyroid Hormone: The National Institutes of Health Prospective Study , 1995, Annals of Internal Medicine.
[238] Nicholas Wc,et al. Single Daily Dose of Methimazole Compared to Every 8 Hours Propylthiouracil in the Treatment of Hyperthyroidism , 1995 .
[239] C. Reasner,et al. Pattern of recovery of the hypothalamic-pituitary-thyroid axis following radioactive iodine therapy in patients with Graves' disease. , 1995, The American journal of medicine.
[240] P. Ladenson,et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association. , 1995, JAMA.
[241] J H Lubin,et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. , 1995, Radiation research.
[242] C. Reiners,et al. Radioiodine therapy of Graves' hyperthyroidism: standard vs. calculated 131 iodine activity * . Results from a prospective, randomized, multicentre study , 1995, European journal of clinical investigation.
[243] D. Wing,et al. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism , 1995 .
[244] R. D'Agostino,et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. , 1994, The New England journal of medicine.
[245] E. Martino,et al. Diagnosis and treatment of thyrotoxicosis in childhood. A European questionnaire study. , 1994, European journal of endocrinology.
[246] P. Larsen,et al. Maternal and Fetal Thyroid Function , 1994 .
[247] A. Kruseman,et al. Bone metabolism during anti‐thyroid drug treatment of endogenous subclinical hyperthyroidism , 1994, Clinical endocrinology.
[248] I. Klein,et al. Beta-Adrenergic Receptor Blocking Drugs in the Management of Hyperthyroidism , 1994 .
[249] G S Levey,et al. Treatment of Hyperthyroid Disease , 1994, Annals of Internal Medicine.
[250] A. Kriplani,et al. Maternal and perinatal outcome in thyrotoxicosis complicating pregnancy. , 1994, European journal of obstetrics, gynecology, and reproductive biology.
[251] H. Blomgren,et al. Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment? , 1994, European journal of endocrinology.
[252] J. Konishi,et al. Metastatic thyroid cancer presenting as thyrotoxicosis: report of three cases , 1994, Clinical endocrinology.
[253] C. Franceschi,et al. Complex alteration of thyroid function in healthy centenarians. , 1993, The Journal of clinical endocrinology and metabolism.
[254] F. Jiménez,et al. Graves' ophthalmopathy after subtotal thyroidectomy and radioiodine therapy , 1993 .
[255] P. Colman,et al. Iodine-induced hyperthyroidism due to nonionic contrast radiography in the elderly. , 1993, The American journal of medicine.
[256] L. Wartofsky,et al. Life-threatening thyrotoxicosis. Thyroid storm. , 1993, Endocrinology and metabolism clinics of North America.
[257] G. Gavaruzzi,et al. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism. , 1993, The Journal of clinical endocrinology and metabolism.
[258] Y. Liaw,et al. Hepatic Injury during Propylthiouracil Therapy in Patients with Hyperthyroidism: A Cohort Study , 1993, Annals of Internal Medicine.
[259] P. Hall,et al. Mortality in patients treated for hyperthyroidism with iodine-131. , 1993, Acta endocrinologica.
[260] J. C. M. van der Vijver,et al. Recurrence of hyperthyroidism in multinodular goiter after long-term drug therapy: A comparison with Graves’ disease , 1992, Journal of endocrinological investigation.
[261] C. Sawin,et al. Low Serum Thyrotropin (Thyroid Stimulating Hormone) in Older Persons without Hyperthyroidism , 1992 .
[262] R. Shore,et al. Issues and epidemiological evidence regarding radiation-induced thyroid cancer. , 1992, Radiation research.
[263] A. Taube,et al. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group. , 1992, The New England journal of medicine.
[264] P. Hall,et al. Cancer mortality after iodine‐131 therapy for hyperthyroidism , 1992, International journal of cancer.
[265] G. Burrow,et al. Thyrotoxicosis in Pregnancy , 1991 .
[266] J. Aguayo,et al. Rapid preoperative preparation in hyperthyroidism , 1991, Clinical endocrinology.
[267] C. Alessi,et al. Low serum free thyroxine index in ambulating elderly is due to a resetting of the threshold of thyrotropin feedback suppression. , 1991, The Journal of clinical endocrinology and metabolism.
[268] P. Hall,et al. Cancer risk after iodine-131 therapy for hyperthyroidism. , 1991, Journal of the National Cancer Institute.
[269] J. Franklyn,et al. Prevalence and follow‐up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom , 1991, Clinical endocrinology.
[270] W. Wiersinga,et al. Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter. , 1990, The American journal of medicine.
[271] D. Ueda. Normal volume of the thyroid gland in children , 1990, Journal of clinical ultrasound : JCU.
[272] H. Gerstein. How common is postpartum thyroiditis? A methodologic overview of the literature. , 1990, Archives of internal medicine.
[273] M. Prummel,et al. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy. , 1990, Archives of internal medicine.
[274] R. Monson,et al. Cancer mortality in women with thyroid disease. , 1990, Cancer research.
[275] Tsukasa Murakami,et al. Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring. , 1990, Archives of internal medicine.
[276] R. Mortimer,et al. Graves'DISEASE IN PREGNANCY: TSH RECEPTOR BINDING INHIBITING IMMUNOGLOBULINS AND MATERNAL AND NEONATAL THYROID FUNCTION , 1990, Clinical endocrinology.
[277] A. Kung,et al. Hyperthyroidism during pregnancy due to coexistence of struma ovarii and Graves' disease. , 1990, Postgraduate medical journal.
[278] J. Nicoloff,et al. Applications of a new chemiluminometric thyrotropin assay to subnormal measurement. , 1990, The Journal of clinical endocrinology and metabolism.
[279] J. Greenhouse,et al. Graves' disease: an analysis of thyroid hormone levels and hyperthyroid signs and symptoms. , 1989, The American journal of medicine.
[280] L Koornneef,et al. Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. , 1989, The British journal of ophthalmology.
[281] L. Degroot,et al. Treatment of Graves' disease and the course of ophthalmopathy. , 1989, The American journal of medicine.
[282] P. Blanc,et al. Lasting remissions in patients treated for Graves' hyperthyroidism with propranolol alone: a pattern of spontaneous evolution of the disease. , 1988, The Journal of clinical endocrinology and metabolism.
[283] O. P. Schumacher,et al. Treatment of childhood Graves' disease. A review with emphasis on radioiodine treatment. , 1988, Cleveland Clinic journal of medicine.
[284] L. Braverman,et al. COMPARISON OF METHIMAZOLE, METHIMAZOLE AND SODIUM IPODATE, AND METHIMAZOLE AND SATURATED SOLUTION OF POTASSIUM IODIDE IN THE EARLY TREATMENT OF HYPERTHYROID GRAVES’DISEASE , 1988, Clinical endocrinology.
[285] T. Reeve,et al. The Preferred Option for Multinodular Goiter , 1987 .
[286] H. Mashiba,et al. Lower serum free thyroxine (T4) levels in painless thyroiditis compared with Graves' disease despite similar serum total T4 levels. , 1987, The Journal of clinical endocrinology and metabolism.
[287] E. Landaw,et al. Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every two years. , 1987, The Journal of clinical endocrinology and metabolism.
[288] R. Janssen,et al. An outbreak of thyrotoxicosis caused by the consumption of bovine thyroid gland in ground beef. , 1987, The New England journal of medicine.
[289] M. Surks,et al. Thyrotoxicosis in the very old. , 1986, The American journal of medicine.
[290] C. Emerson,et al. Euthyroid hyperthyroxinemia and thyroxine-binding prealbumin excess in islet cell carcinoma. , 1985, The Journal of clinical endocrinology and metabolism.
[291] J. Hamburger. Management of hyperthyroidism in children and adolescents. , 1985, The Journal of clinical endocrinology and metabolism.
[292] D. Cooper. Propylthiouracil levels in hyperthyroid patients unresponsive to large doses. Evidence of poor patient compliance. , 1985, Annals of internal medicine.
[293] C. Haffajee,et al. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. , 1984, Annals of internal medicine.
[294] J. Feely,et al. Beta‐adrenoceptor blockade and anaesthesia for thyroidectomy , 1984, Anaesthesia.
[295] I. Hart,et al. Follow-up of solitary autonomous thyroid nodules treated with 131I. , 1983, The New England journal of medicine.
[296] G. Geelhoed. Surgery of the endocrine glands in pregnancy. , 1983, Clinical obstetrics and gynecology.
[297] J. Mckenzie,et al. Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism. , 1983, The Journal of clinical endocrinology and metabolism.
[298] J. Lazarus,et al. Aetiology of hyperthyroidism in Canada and Wales. , 1983, Journal of epidemiology and community health.
[299] M. Mcdermott,et al. Radioiodine-induced thyroid storm. Case report and literature review. , 1983, The American journal of medicine.
[300] J. Fradkin,et al. Iodide‐Induced Thyrotoxicosis , 1983, Lancet.
[301] R. W. Miller,et al. Treatment of lymphocytic thyroiditis with spontaneously resolving hyperthyroidism (silent thyroiditis). , 1982, Archives of internal medicine.
[302] P. Laurberg,et al. A longitudinal study of serum TSH, and total and free iodothyronines during normal pregnancy. , 1982, Acta endocrinologica.
[303] A. Pinchera,et al. Low serum thyroglobulin as a clue to the diagnosis of thyrotoxicosis factitia. , 1982, The New England journal of medicine.
[304] L. Holm,et al. Incidence of hypothyroidism occurring long after iodine-131 therapy for hyperthyroidism. , 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[305] P. Woolf. Transient painless thyroiditis with hyperthyroidism: a variant of lymphocytic thyroiditis? , 1980, Endocrine reviews.
[306] E. de Juan,et al. Racial differences in normal values of proptosis. , 1980, Archives of internal medicine.
[307] H. Bank,et al. Propylthiouracil-induced hepatic damage. , 1980, Archives of internal medicine.
[308] J. Brosseau,et al. Lymphocytic thyroiditis with spontaneously resolving hyperthyroidism (silent thyroiditis). , 1980, Archives of internal medicine.
[309] J. Loré. Surgery of the thyroid gland. , 1980, Otolaryngologic clinics of North America.
[310] D. Swanson,et al. Iodine-131: optimal therapy for hyperthyroidism in children and adolescents? , 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[311] K. Chung,et al. AMIODARONE AND THE THYROID , 1979, The Lancet.
[312] M. Weiss,et al. [Thyrotoxicosis in pregnancy]. , 1979, Harefuah.
[313] R. Carretta,et al. The increasing incidence of hypothyroidism within one year after radioiodine therapy for toxic diffuse goiter. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[314] J. Turner,et al. LITHIUM AS AN ADJUNCT TO RADIOIODINE THERAPY FOR THYROTOXICOSIS , 1976, The Lancet.
[315] B. M. Dobyns,et al. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study. , 1974, The Journal of clinical endocrinology and metabolism.
[316] F. B. Davis,et al. Hyperthyroidism in patients over the age of 60 years. Clinical features in 85 patients. , 1974, Medicine.
[317] J. Korf,et al. Clinical significance of probenecid test. , 1973, Lancet.
[318] D. Becker,et al. Complications of radioiodine treatment of hyperthyroidism. , 1971, Seminars in nuclear medicine.
[319] B. Senior,et al. Iodide goiter in the newborn. , 1971, Pediatrics.
[320] A. Keats,et al. The risk of anesthesia. , 1970, Clinical engineering information service.
[321] Dolphin Gw. The risk of thyroid cancers following irradiation. , 1968 .
[322] R. Segal,et al. Thyrocardiac disease and its management with radioactive iodine I-131. , 1961, JAMA.
[323] L. Eisenberg. Thyrotoxicosis complicating pregnancy. , 1950, New York state journal of medicine.
[324] I. Klein. Endocrine Disorders and Cardiovascular Disease , 2012 .
[325] Ross Ward,et al. American Association of Clinical Endocrinologists , 2011 .
[326] I. Klein,et al. Effects of amiodarone therapy on thyroid function , 2010, Nature Reviews Endocrinology.
[327] A. Pinchera,et al. Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal. , 2010, The Journal of clinical endocrinology and metabolism.
[328] Paolo Vitti,et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and EuropeanThyroid Association Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules. , 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[329] A. Morris,et al. Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. , 2010, The Journal of clinical endocrinology and metabolism.
[330] P. Laurberg,et al. Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy. , 2009, European journal of endocrinology.
[331] L. Tanoue,et al. A Clinical Blueprint to Accelerate the Elimination of Tobacco Use , 2009 .
[332] O. Tørring,et al. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. , 2008, European journal of endocrinology.
[333] M. Castellano,et al. The role of imaging in Graves' disease: a cost-effectiveness analysis. , 2008, European journal of radiology.
[334] J. Stockman. Primary Thyroid Cancer After a First Tumour in Childhood (the Childhood Cancer Survivor Study): A Nested Case-Control Study , 2007 .
[335] E. Mazzaferri. Thyroid Status, Cardiovascular Risk, and Mortality in Older Adults , 2007 .
[336] S. Rivkees. The Treatment of Graves' Disease in Children , 2006, Journal of pediatric endocrinology & metabolism : JPEM.
[337] A. Weetman. Graves' hyperthyroidism: how long should antithyroid drug therapy be continued to achieve remission? , 2006, Nature Clinical Practice Endocrinology &Metabolism.
[338] A. Chang,et al. Habit cough, tic cough, and psychogenic cough in adult and pediatric populations: ACCP evidence-based clinical practice guidelines. , 2006, Chest.
[339] G. Guyatt,et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. , 2006, Chest.
[340] B. Goichot,et al. Antithyroid drugs , 2005, The New England journal of medicine.
[341] Ph.D. Brown M. Dobyns M.D.. Prevention and management of hyperthyroid storm , 2005, World Journal of Surgery.
[342] A. Avenell,et al. Antithyroid drug regimen for treating Graves' hyperthyroidism. , 2005, The Cochrane database of systematic reviews.
[343] C. Carella,et al. Clinical review 169: Interferon-alpha-related thyroid disease: pathophysiological, epidemiological, and clinical aspects. , 2004, The Journal of clinical endocrinology and metabolism.
[344] D. Farley,et al. Surgical Management of Amiodarone-associated Thyrotoxicosis: Mayo Clinic Experience , 2004, World Journal of Surgery.
[345] H. Burch,et al. Thyroid cancer yield in patients with Graves' disease. , 2003, Minerva endocrinologica.
[346] E. Salpeter,et al. Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis. , 2002, Annals of internal medicine.
[347] H. Röher,et al. [Complications in thyroid surgery. Incidence and therapy]. , 1999, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.
[348] K. Usadel,et al. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. , 1999, The Journal of clinical endocrinology and metabolism.
[349] A. Corrias,et al. Factors at Onset Predictive of Lasting Remission in Paediatric Patients with Graves' Disease Followed for at Least Three Years , 1999, Journal of pediatric endocrinology & metabolism : JPEM.
[350] J. Boice. Radiation and thyroid cancer: what more can be learned? , 1998, Acta oncologica.
[351] M. Doody,et al. Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. , 1998, JAMA.
[352] P. Yeo,et al. Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature. , 1997, Thyroid : official journal of the American Thyroid Association.
[353] N. Qvist,et al. Experience in a specialist thyroid surgery unit: a demographic study, surgical complications, and outcome. , 1997, The European journal of surgery = Acta chirurgica.
[354] J. D. Bass,et al. Single daily dose of methimazole compared to every 8 hours propylthiouracil in the treatment of hyperthyroidism. , 1995, Southern medical journal.
[355] G. Benker,et al. Antithyroid drug — induced agranulocytosis: Clinical experience with ten patients treated at one institution and review of the literature , 1994, Journal of endocrinological investigation.
[356] P. Vos,et al. The measurement of fecal thyroxine in the diagnosis of thyrotoxicosis factitia. , 1993, Thyroid : official journal of the American Thyroid Association.
[357] E. Torres Vela,et al. Graves' ophthalmopathy after subtotal thyroidectomy and radioiodine therapy. , 1993, The British journal of surgery.
[358] J. Orcutt,et al. Graves' ophthalmopathy. , 1992, The Western journal of medicine.
[359] P. Wilson,et al. Low serum thyrotropin (thyroid-stimulating hormone) in older persons without hyperthyroidism. , 1991, Archives of internal medicine.
[360] S. Nagataki,et al. Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States. , 1991, Thyroid : official journal of the American Thyroid Association.
[361] E. Mazzaferri,et al. Sensitivity, specificity, and cost-effectiveness of the sensitive thyrotropin assay in the diagnosis of thyroid disease in ambulatory patients. , 1989, Archives of internal medicine.
[362] J. Greenhouse,et al. A psychiatric and neuropsychological study of patients with untreated Graves' disease. , 1988, General hospital psychiatry.
[363] O. Clark. Total thyroidectomy: the preferred option for multinodular goiter. , 1988, Annals of surgery.
[364] P. Laurberg,et al. Goitre size and outcome of medical treatment of Graves' disease. , 1986, Acta endocrinologica.
[365] P. Ladenson,et al. Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. , 1983, Annals of internal medicine.
[366] L. Braverman,et al. Euthyroid hyperthyroxinemia , 1983, Journal of endocrinological investigation.
[367] G. Dolphin. The risk of thyroid cancers following irradiation. , 1968, Health physics.
[368] W. Fisher,et al. Congenital hypothyroidism in infant following maternal I131 therapy , 1963 .
[369] W. Fisher,et al. Congenital hypothyroidism in infant following maternal I-131 therapy with a review of hazards of environmental radioisotope contamination. , 1963, The Journal of pediatrics.
[370] G. Sheline,et al. Thyroid nodules occurring late after treatment of thyrotoxicosis with radioiodine. , 1962, The Journal of clinical endocrinology and metabolism.